Potent inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50
= 15.8 nM). Displays >1000-fold selectivity for DPP-IV over DPP-8 and DPP-9. Improves glucose tolerance in a mouse oral glucose tolerance assay.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Indole- and indazole-based inhibitors of dipeptidyl peptidase IV for the treatment of type 2 diabetes.
Tozer et al.
32nd Annual National Medicinal Chemistry Symposium, 2010;:Poster 52